Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to www.bayer.com.
IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. IQVIA enables companies to rethink approaches to clinical development and commercialization, innovate with confidence as well as accelerate meaningful healthcare outcomes. IQVIA has approximately 55,000 employees in more than 100 countries, all committed to making the potential of human data science a reality. IQVIA’s approach to human data science is powered by the IQVIA CORE™, driving unique actionable insights at the intersection of big data, advanced technology and analytics with extensive industry knowledge.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing the information that helps their customers drive human health outcomes forward. IQVIA’s insights and execution capabilities help biotech, medical device, and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.IQVIA.com.
DSM Group operates on the pharmaceutical market as a marketing research agency since 1999. The Agency provides its clients with a unique opportunity to use in their work the data of retail audit, hospital audit and audit of preferential drug provision in the CIS countries (Russia, Ukraine, Kazakhstan, Belarus, Moldova, etc.). The unique service approach that DSM Group uses in its products allows the clients to receive the accurate data about the market very operatively. The production process of retail audit of DSM Group meets the requirements of ISO 9001:2015. The company also provides its customers (in 2018 the number of current clients reached 328 companies) a wide range of marketing services: surveys and focus groups of pharmacists and doctors, market researches, advertising and conference services in Russia and abroad. DSM Group analyzes the capacity and trends of the market regularly, and shares the information in Newspapers and business magazines. The newspaper "Pharmacy and medicine" together with DSM Group have the largest presence on the market (30 000 copies every 2 weeks). Our clients are the leading Russian and world manufacturers on pharmaceutical market. Our data is used by governmental ministries and departments. Since 2006, DSM Group is a member of the European Association of market and public opinion researchers (ESOMAR).
Proxima Research International is an international group of companies, which includes key solution-vendors for the life-science industry in CIS & Eastern Europe countries, covering the complete scope of pharma-companies needs in IT-solutions, data for decision-making and product promotion for the last 20 years. Proxima Research International provides expert solutions for Pharma. The main areas are CRM integration and support, HCP/HCO database management, omni-channel marketing, AI, business intelligence, IT-development, market data, marketing research and consulting
The analytical company AlphaRM provides a full range of analytical and marketing services in pharmaceuticals.
Core projects :
· Audit of medicinal products retail sales (sell out)
· Audit of medicinal products purchases by pharmacy institutions (sell in)
· Geomarketing for pharmacy institutions
· Audit of medicinal products shipments to health care facilities
· Audit of the federal segment for preferential provision of medicinal products
· Audit of the regional segment for preferential provision of medicinal products
· Certification in pharmaceutical segment
· Monitoring of public procurement
· Audit of the target segment for medicinal products delivery
CV PROTEK is a leading national distributor of pharmaceutical products in Russia.
CV PROTEK has a logistic and warehouse system that complies with world standards and is capable of bringing products maximally close to the end consumer. The company’s large-scale regional chain is comprised of 42 branches and covers the entire territory of the Russian Federation.
Established in 1990, CV Protek has for the past 25 years set the vector of development of the entire distribution segment, demonstrating continuous development and offering innovative business solutions to its partners and clients.
CV PROTEK is part of PROTEK Group of Companies.
The communication group «Aaron Lloyd» is a media agency, working in the pharmaceutical market since 1999.
We have a lot of expert employees, including a Medical director, who provide additional support to our clients in relation to marketing.
We are involved in strategic and tactical media-planning, econometric modelling and implement unusual projects and 360° campaigns. We also provide educational programs for our Clients.
«Aaron Lloyd» agency is the only subscriber for industrial data from QuintilesIMS and Alpharm.
From 2014 the agency has been a strategic partner of Dentsu Aegis Network group in Russia.
From 2016 a special medical program «Agents 003» is broadcast on TNT channel with involvement of the Agency «Aaron Lloyd».
The marketing agency RX Code is one of the leaders in the Russian market of pharmaceutical products and medical equipment promotion.
The company is an expert in the provision of services for personnel outsourcing, remote communication with doctors and pharmacies, organization of training courses and special social projects, as well as in creative solutions for all types of media.
Ipsos Healthcare Russia as a part of the Global Ipsos Healthcare specializes on Russian Healthcare market for over past two decades and working with the most of market players and their HQs.
Deep understanding of the Russian healthcare and pharmaceutical market coupled with a wide range of analytical services and modern research tools allows us to keep a leading position in this segment.
Almost 50 employees Ipsos Healthcare (Russia) focusing exclusively on Healthcare research and offering a full range of services in the following areas: Syndicated research, Custom research (AdHoc), Analytics and consultancy and Educational trainings.
Our Syndicated Surveys cover over 15 000 physicians and more than 4 500 pharmacists annually providing our clients with actual and precise data on the Russian pharmaceutical market.
Custom research both for Qualitative and Quantitative parts and also supporting by our Analytics&Consultancy service allows our clients to update regularly market feedback on various segments.
Educational project School of Pharmaceutical Marketing within last 9 years offers a wide range of educational workshop and training programs conducted by leading trainers and market experts.
For more than 65 years Baker McKenzie has been effectively providing global advice in the pharmaceutical sector, and for over 25 of those years providing such advice here in the CIS. The size and global reach of our Firm, with its 77 offices in 47 countries, guarantee that know-how is shared among jurisdictions and allow resources from our international network to supplement local office needs. Having assisted in the foundation of the Association of International Pharmaceutical Manufacturers and the International Medical Devices Manufacturers Association, we advise clients on the full spectrum of legal concerns in the CIS, including customs and trade regulation, as well as WTO and EurAsEC-consistent policy. (www.bakermckenzie.com)www.bakermckenzie.com
Established in 1994. The Association comprises 60 international pharmaceutical companies that provide over 80% of the world’s pharmaceutical products and over 60% of medicines imported to the Russian Federation.
To promote economic and legal policies that focus on the development of organized and open pharmaceutical market, improving of medical services quality and expansion of the range of modern medicines for the benefit of Russian people.
Remedium group of Companies renders the whole range of services for specialists in the field of medicine and pharmaceutics. For years the principle directions of activity of “Remedium” Group of Companies are publication of particularized periodicals, assignment of electronic databases, arrangement and implementation of measures, rent-a-rep service, organization of advertisement and PR support.